GSK plc (GLAXF)
OTC
Closed
Aug 21, 2026
Day's Range
24.9552 wk Range
18.99Overview - GLAXF - GSK plc
Key Statistics
Valuation
Enterprise Value
159.48B
P/E (Trailing)
‪15.93‬
P/E (Forward)
‪11.59‬
PEG Ratio
‪-0.22‬
Price / Sales (TTM)
‪3.07‬
Price / Book
‪4.27‬
EV / EBITDA
‪10.80‬
Profitability
Gross Margin
‪73.05%‬
Profit Margin
‪14.52%‬
Operating Margin
‪30.94%‬
Return on Assets
‪10.00%‬
Return on Equity
‪33.38%‬
Ownership
Shares Outstanding
4.00B
Float
3.88B
Held by Insiders
‪1.74%‬
Held by Institutions
‪48.18%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪25.75‬
200-Day Avg
‪25.82‬
Dividends
Payout Ratio
‪56.88%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GLAXF - GSK plc
Peers - GLAXF - GSK plc
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
Profile Summary - GLAXF - GSK plc
About
GSK plc is a global biopharma company dedicated to uniting science, technology, and talent to get ahead of disease. Its primary purpose is to positively impact the health of 2.5 billion people by the end of the decade through innovative prevention and treatment strategies. The company focuses its research and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
